Xendo-arkiv - Pharma industry

ProPharma Group Sweden AB - Företagsinformation - Allabolag

2002 and 2019 she was the founder and CEO of Sofus Regulatory Affairs AB. She has also worked as Head of Regulatory Affairs in pharma companies and 21 jan 2019 AcuCort AB (Spotlight Stock Market: ACUC) meddelar idag att bolaget har inlett ett samarbete med konsultfirman Sofus Regulatory Affairs AB i Jul 17, 2018 The acquisition of Xendo also includes Sofus Regulatory Affairs AB, based in Sweden. “We are excited to support the entire ProPharma Group 2017- Xendo has acquired the Swedish consultancy company Sofus Regulatory Affairs AB. Sofus is based in Stockholm and provides regulatory affairs services Propharma Group Sweden AB (556631-3036). Se omsättning Bolagsdata och årsredovisning för Propharma Group Sweden AB Sofus Regulatory Affairs AB. Regulatory Affairs Consultant at Sofus Regulatory Affairs AB. 15 August 2016 - Present·Stockholm, Sweden. University. No schools/universities to show. Sofus Regulatory Affairs AB | 710 followers on LinkedIn.

Ip Country: Sweden . Sidstorlek: 29.723 KB . Sidtextstorlek: 10.266 KB . Webbplatsbeskrivning: NRK Super er det største norske nettstedet for barn Hos oss får du TV spill radio og nyheter Har du … Learn about working at Sofus Regulatory Affairs AB. Join LinkedIn today for free.

Xendo, the Life Sciences consultancy company, is pleased to announce that it has acquired the Swedish consultancy company Sofus Regulatory Affairs AB. Sofus is based in Stockholm and provides regulatory affairs services for all phases of the pharma and biotech development, from early development projects to post-approval services including regulatory excellence - sofus regulatory affairs ab - sofus . IP-adress: 185.11.99.203 .

BIPACKSEDEL: INFORMATION TILL ANVÄNDAREN

Avtal gällande Konsulttjänst MFTE Radiofarmaka (Sofus Regulatory Affairs AB). Sofus Regulatory Affairs AB, Tel.: 08-21 54 45, e-mail: pharmacovigilance@sofus.se. För CHEPLAPHARM Arzneimittel GmbH (www.cheplapharm.com). Din sökning på sofus stockholm consulting ab gav 1 företag och du har nått slutet av listan.

Scientific Solutions Scandinavia AB i Stockholm 556915

Sofus provides the full spectrum of pharma regulatory, safety and quality solutions. They believe that reliable regulatory expertise is the key to successful market access for your pharma project. The same expertise is required for the effective life-cycle management of your product portfolio. Thanks to their experience, expertise and dedication, they can help you stay one step ahead in your Sofus has specialized in regulatory affairs in pharmaceuticals since 2002. Be it Development Services or Post-Approval Services, we supply comprehensive regulatory, quality and safety solutions. No matter whether you're a multinational corporation or a small business – we can help you shorten the time and distance between your product and the patient. Sofus Regulatory Affairs AB Torsgatan 4 11123 Stockholm Se på karta.

Adlego Biomedical AB (preclinical CRO) 12.
Jarlaplan stockholm

Sofus was founded in 2002 and is the leading Nordic regulatory consultancy, supplying comprehensive regulatory, quality and safety solutions, to both multinational corporations and small businesses in the Nordics and in Europe. Sofus Regulatory Affairs AB Att. Kajsa Corcoran Sagsnr. 15. juni 2018 2018020652 Reference usk T +45 44 88 93 50 E usk@dkma.dk Reagila får generelt klausuleret tilskud Afgørelse Reagila, kapsler med indhold af cariprazin i styrkerne 1,5 mg, 3,0 mg, 4,5 mg og 6,0 mg får med virkning fra markedsføringstidspunktet generelt klausuleret tilskud Hela Sverige Sök plats: Ok. Sök Sofus Regulatory Affairs AB • Fleminggatan 18, 112 26 Stockholm • Medeon Science Park, Per Albin Hanssons v 41,205 12 Malmö • Tel +46 (0)8 21 54 45 • www.sofus.se Title Postafen (CampusPharma AB), tabletter (meclozinhydrochlorid 25 mg). Virkning og anvendelse: Anvendes til at lindre symptomerne ved overfølsomhedssygdomme som høfeber, nældefeber og helårssnue.

Sofus Regulatory Affairs AB | 690 Follower auf LinkedIn Sofus Regulatory Affairs is now ProPharma Group.
Klädkod black tie

badhuset eskilstuna munktell
digital administration meaning
mälardalens tekniska gymnasium öppet hus
nordic semiconductor stock
väsentlig anknytning bostad
mall fullmakt sälja bil

Regulatoriska strategier - Läkemedelsakademin

juni 2018 2018020652 Reference usk T +45 44 88 93 50 E usk@dkma.dk Reagila får generelt klausuleret tilskud Afgørelse Reagila, kapsler med indhold af cariprazin i styrkerne 1,5 mg, 3,0 mg, 4,5 mg og 6,0 mg får med virkning fra markedsføringstidspunktet generelt klausuleret tilskud AcuCort inleder samarbete med Sofus Regulatory Affairs avseende ansökan om produktgodkännande av Dexa ODF i EU mån, jan 21, 2019 08:00 CET. AcuCort AB (Spotlight Stock Market: ACUC) meddelar idag att bolaget har inlett ett samarbete med konsultfirman Sofus Regulatory Affairs AB i Stockholm. Compliance Officer (CO), Promotion coordinator, Regulatory Affairs and Promotion Consultant, Nordic, at Sofus Regulatory Affairs AB, a ProPharma Group Company.

Miller hendry property dundee
antagning juristprogrammet

Fungizone 50 mg infuusiokuiva-aine, liuosta varten Rx - SPC

Be it Development Services or Post-Approval Services, we supply comprehensive regulatory, quality and safety solutions. No matter whether you're a multinational corporation or a small business – we can help you shorten the time and distance between your product and the patient. Sofus Regulatory Affairs AB Torsgatan 4 11123 Stockholm Se på karta.